Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: Does methicillin resistance matter?

Infection Control and Hospital Epidemiology

Volumn 31, Issue 6, 2010, Pages 584-591

  Honda, Hitoshi ^a   Krauss, Melissa J ^a   Coopersmith, Craig M ^a   Kollef, Marin H ^a   Richmond, Amy M ^b   Fraser, Victoria J ^a   Warren, David K ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HOSPITAL PATIENT; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INTENSIVE CARE UNIT PATIENT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; NOSE; PENICILLIN RESISTANCE; PROSPECTIVE STUDY; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; COHORT STUDIES; CROSS INFECTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MISSOURI; NASAL CAVITY; PATIENT ADMISSION; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 77952150582     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/652530     Document Type: Article

References (39)

1. Calfee DP, Salgado CD, Classen D, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 (suppl 1):S62-S80.
2. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Inject Control 2004; 32 (8):470-485.
3. Jarvis WR, Schlosser J, Chinn RY, Tweeten S, Jackson M. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control 2007; 35 (10):631-637. (Pubitemid 350184164)
4. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39 (6):776-782.
5. Huang SS, Piatt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36(3):281-285. (Pubitemid 36169662)
6. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002;162(19):2229-2235.
7. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a metaanalysis. Clin Infect Dis 2003; 36 (1):53-59. (Pubitemid 36099097)
8. Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46 (2):193-200. (Pubitemid 351269157)
9. Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillinresistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46 (5):752-760.
10. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002; 136 (11):834-844. (Pubitemid 34568654)
11. Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008; 121 (4):310-315.
12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of healthcare- associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36 (5):309-332. (Pubitemid 351763841)
13. Kleinbaum DG, Klein M. Survival Analysis: A self-learning text. 2nd ed. New York, NY: Springer; 2005.
14. Schoenfeld D. Partial residuals for the proportional hazards model. Biometrika 1982;69:51-55.
15. Andersen PK, Gill RD. Cox regression model for counting processes: a large sample study. Ann Stat 1982;10:1100-1120.
16. Warren DK, Guth RM, Coopersmith CM, Merz LR, Zack JE, Fraser VJ. Epidemiology of methicillin-resistant Staphylococcus aureus colonization in a surgical intensive care unit. Inject Control Hosp Epidemiol 2006; 27(10):1032-1040. (Pubitemid 44670978)
17. Oztoprak N, Cevik MA, Akinci E, et al. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections. Am J Infect Control 2006;34(1):1-5. (Pubitemid 43144348)
18. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Cut Care Med 1998; 157:531-539. (Pubitemid 28090546)
19. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39(7): 971-979. (Pubitemid 39313452)
20. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364 (9435): 703-705. (Pubitemid 39140626)
21. Garrouste-Orgeas M, Timsit JF, Kallel H, et al. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol 2001; 22 ( 11): 687-692. (Pubitemid 34132008)
22. Corbella X, Dominguez MA, Pujol M, et al. Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1997; 16 (5): 351-357. (Pubitemid 27271822)
23. Keene A, Vavagiakis P, Lee MH, et al. Staphylococcus aureus colonization and the risk of infection in critically ill patients. Infect Control Hosp Epidemiol 2005; 26 (7):622-628. (Pubitemid 41073402)
24. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148 (6):409-418. (Pubitemid 351665440)
25. Harbarth S, Huttner B, Gervaz P, et al. Risk factors for methicillin-resistant Staphylococcus aureus surgical site infection. Inject Control Hosp Epidemiol 2008; 29 (9):890-893.
26. Roghmann MC, Siddiqui A, Plaisance K, Standiford H. MRSA coloni- zation and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. J Hosp Infect 2001;47(2):98-103. (Pubitemid 32181722)
27. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129(5):1210-1218.
28. Anderson DJ, Chen LF, Schmader KE, et al. Poor functional status as a risk factor for surgical site infection due to methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2008; 29 (9):832-839.
29. Agbaht K, Lisboa T, Pobo A, et al. Management of ventilator-associated pneumonia in a multidisciplinar)' intensive care unit: does trauma make a difference? Intensive Care Med 2007; 33 (8):1387-1395. (Pubitemid 47101722)
30. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346(24): 1871-1877. (Pubitemid 34605989)
31. Walsh TJ, Standiford HC, Reboli AC, et al. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother 1993; 37 (6):1334-1342.
32. Wendt C, Schinke S, Wurttemberger M, Oberdorfer K, Bock-Hensley O, von Baum H. Value of whole-body washing with Chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 2007; 28 (9): 1036-1043. (Pubitemid 47345262)
33. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of Chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillinresistant Staphylococcus aureus colonization. Clin Infect Dis 2007;44(2): 178-185. (Pubitemid 46079977)
34. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Inject Control Hosp Epidemio/2008;29(6):510-516. (Pubitemid 351918029)
35. Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007;45(5):541-547. (Pubitemid 47328632)
36. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43 (6):1412-1416. (Pubitemid 29259335)
37. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344(1): 11-16. (Pubitemid 32064839)
38. Coello R, Jimenez J, Garcia M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994; 13(1):74-81. (Pubitemid 24060896)
39. Yang ES, Tan J, Eells S, Rieg G, Tagudar G, Miller LG. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect 2009; 16:425.